Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2
Journal of Allergy and Clinical Immunology · 2023-09 · 152 (3) · 771-782
DOI: 10.1016/j.jaci.2023.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-09. Verfasst von Liang Chen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Hauptthemen laut MEDLINE: Adenosine Deaminase, Vasculitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Pfizer, American Academy of Pediatrics, Bristol-Myers Squibb.
Abstract (Originalsprache)
BACKGROUND: Deficiency of adenosine deaminase 2 (DADA2) results in heterogeneous manifestations including systemic vasculitis and red cell aplasia. The basis of different disease phenotypes remains incompletely defined. OBJECTIVE: We sought to further delineate disease phenotypes in DADA2 and define the mechanistic basis of ADA2 variants. METHODS: We analyzed the clinical features and ADA2 variants in 33 patients with DADA2. We compared the transcriptomic profile of 14 patients by bulk RNA sequencing. ADA2 variants were expressed experimentally to determine impact on protein production, trafficking, release, and enzymatic function. RESULTS: Transcriptomic analysis of PBMCs from DADA2 patients with the vasculitis phenotype or pure red cell aplasia phenotype exhibited similar upregulation of TNF, type I interferon, and type II interferon signaling pathways compared with healthy controls. These pathways were also activated in 3 asymptomatic individuals with DADA2. Analysis of ADA2 variants, including 7 novel variants, showed different mechanisms of functional disruption including (1) unstable transcript leading to RNA degradation; (2) impairment of ADA2 secretion because of retention in the endoplasmic reticulum; (3) normal expression and secretion of ADA2 that lacks enzymatic function; and (4) disruption of the N-terminal signal peptide leading to cytoplasmic localization of unglycosylated protein. CONCLUSIONS: Transcriptomic signatures of inflammation are observed in patients with different disease phenotypes, including some asymptomatic individuals. Disease-associated ADA2 variants affect protein function by multiple mechanisms, which may contribute to the clinical heterogeneity of DADA2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
- Federal State Autonomous Institution "National Medical Research Center for Children's Health" of the Ministry of Health of the Russian Federation, Moscow, Russia.
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
- NRC Institute of Immunology FMBA of Russia, Moscow, Russia.
- Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Department of Pediatrics, Maine Medical Center, Portland, Me.
Förderung
- Pfizer
- American Academy of Pediatrics
- Bristol-Myers Squibb
- Boston Children's Hospital
Zitieren
APA
Chen, L., Mamutova, A., Kozlova, A., Latysheva, E., Evgeny, F., Latysheva, T., Savostyanov, K., Pushkov, A., Zhanin, I., Raykina, E., Kurnikova, M., Mersiyanova, I., Platt, C. D., Jee, H., Brodeur, K., Du, Y., Liu, M., Weiss, A., Schulert, G. S., …, & Lee, P. Y. (2023). Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2. Journal of Allergy and Clinical Immunology, 152(3), 771-782. https://doi.org/10.1016/j.jaci.2023.04.014
Vancouver
Chen L, Mamutova A, Kozlova A, Latysheva E, Evgeny F, Latysheva T, et al. Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2. Journal of Allergy and Clinical Immunology. 2023;152(3):771-782. doi:10.1016/j.jaci.2023.04.014
BibTeX
@article{Chen2023,
author = {Chen, Liang and Mamutova, Anna and Kozlova, Anna and Latysheva, Elena and Evgeny, Frolov and Latysheva, Tatiana and Savostyanov, Kirill and Pushkov, Alexander and Zhanin, Ilya and Raykina, Elena and Kurnikova, Maria and Mersiyanova, Irina and Platt, Craig D and Jee, Hyuk and Brodeur, Kailey and Du, Yan and Liu, Meng and Weiss, Aaron and Schulert, Grant S and Rodriguez-Smith, Jackeline and Hershfield, Michael S and Aksentijevich, Ivona and Zhou, Qing and Nigrovic, Peter A and Shcherbina, Anna and Alexeeva, Ekaterina and Lee, Pui Y},
title = {Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
volume = {152},
number = {3},
pages = {771--782},
doi = {10.1016/j.jaci.2023.04.014}
}
EUVIMED